Loading...
TransMedics Group, Inc.
TMDX•NASDAQ
Healthcare
Medical - Devices
$108.12
$1.33(1.25%)
TransMedics Group, Inc. (TMDX) Financial Performance & Income Statement Overview
Review TransMedics Group, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
82.74%
↑ 82.74%
Operating Income Growth
230.53%
↑ 230.53%
Net Income Growth
241.70%
↑ 241.70%
Operating Cash Flow Growth
474.60%
↑ 474.60%
Operating Margin
10.76%
↑ 10.76%
Gross Margin
59.45%
↑ 59.45%
Net Profit Margin
10.03%
↑ 10.03%
ROE
21.88%
↑ 21.88%
ROIC
6.72%
↑ 6.72%
TransMedics Group, Inc. (TMDX) Income Statement & Financial Overview
Review TransMedics Group, Inc.'s (TMDX) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $121.62M | $108.76M | $114.31M | $96.85M |
Cost of Revenue | $49.61M | $47.92M | $45.14M | $36.99M |
Gross Profit | $72.01M | $60.84M | $69.16M | $59.86M |
Gross Profit Ratio | $0.59 | $0.56 | $0.61 | $0.62 |
R&D Expenses | $16.46M | $14.27M | $13.86M | $11.38M |
SG&A Expenses | $46.91M | $42.66M | $42.80M | $36.06M |
Operating Expenses | $63.37M | $56.92M | $56.65M | $47.44M |
Total Costs & Expenses | $112.98M | $104.84M | $101.80M | $84.43M |
Interest Income | -$10.50M | $0.00 | $3.40M | $3.57M |
Interest Expense | $3.57M | $0.00 | $3.62M | $3.60M |
Depreciation & Amortization | $5.68M | $9.12M | $4.60M | $4.40M |
EBITDA | $16.24M | $13.04M | $17.11M | $16.82M |
EBITDA Ratio | $0.13 | $0.12 | $0.15 | $0.17 |
Operating Income | $8.64M | $3.92M | $12.51M | $12.42M |
Operating Income Ratio | $0.07 | $0.04 | $0.11 | $0.13 |
Other Income/Expenses (Net) | -$1.66M | $322000.00 | -$355000.00 | -$28000.00 |
Income Before Tax | $6.99M | $4.25M | $12.15M | $12.39M |
Income Before Tax Ratio | $0.06 | $0.04 | $0.11 | $0.13 |
Income Tax Expense | $132000.00 | $29000.00 | -$41000.00 | $196000.00 |
Net Income | $6.86M | $4.22M | $12.19M | $12.20M |
Net Income Ratio | $0.06 | $0.04 | $0.11 | $0.13 |
EPS | $0.20 | $0.13 | $0.37 | $0.37 |
Diluted EPS | $0.19 | $0.12 | $0.35 | $0.35 |
Weighted Avg Shares Outstanding | $33.59M | $33.44M | $33.12M | $32.76M |
Weighted Avg Shares Outstanding (Diluted) | $35.21M | $35.68M | $35.29M | $34.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan